Loading…
Reported covered position: Legislative Assistant, Senator Lieberman May 2011-June 2012; Senior Legislative Assistant, Rep.Dan Boren June 2008-July 2011.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CENCORA, INC. · Firm: INLET STRATEGIES
HR 1: The One Big Beautiful Bill Act Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands
Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of biosimilars within Medicare Part D Issues related to the strategic national stockpile Issues related to the procurement of the medicine "Udenyca" for the treatment of acute radiation exposure
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CENCORA, INC. via INLET STRATEGIES
2026 · third_quarter · Q3
Issues related to drug shortages and the medical supply chain. Issues related to the federal tax rate of corporations and their inventory. Issues related to health care consolidation and business acquisitions.
Issues related to drug shortages and the medical supply chain Issues related to the federal tax rate of corporations and their inventory Issues related to health care consolidation and acquisitions.
Source: Senate LDA
Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D Issues related to the strategic national stockpile Issues related to the procurement of the medicine "Udenyca" for the treatment of acute radiation exposure
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act
Modernizing and Ensuring PBM Accountability Act
Client: CENCORA, INC. · Firm: INLET STRATEGIES
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
Ensuring Justice for Victims of Terrorism Act
Client: COHERUS BIOSCIENCES, INC · Firm: INLET STRATEGIES
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2026 · third_quarter · Q3
Issues related to fraud in the Medicare Hospice Program Issues related to Hospice and the Medicare Advantage Program Issues related to Medicare fraud and the moratorium issued by CMS
Issues related fraud in the Medicare Hospice Program. Issues related to Hospice and the Medicare Advantage Program Issues related to Medicare fraud and the CMS hospice moratorium
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2026 · third_quarter · Q3
Federal Financial Support for the American Biotech Industry Issues related to the procurement of the medicine Udenyca
Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry Issues related to the procurement of the medicine Udenyca
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2026 · second_quarter · Q2
Issues related to drug shortages and the medical supply chain Issues related to the federal tax rate of corporations and their inventory Issues related to health care consolidation and acquisitions.
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
Issues related to drug shortages and the medical supply chain. Issues related to the federal tax rate of corporations and their inventory. Issues related to health care consolidation and business acquisitions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2026 · second_quarter · Q2
Issues related to fraud in the Medicare Hospice Program Issues related to Hospice and the Medicare Advantage Program
Issues related fraud in the Medicare Hospice Program. Issues related to Hospice and the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2026 · second_quarter · Q2
Federal Financial Support for the American Biotech Industry
Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2026 · first_quarter · Q1
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2026 · first_quarter · Q1
Issues related fraud in the Medicare Hospice Program. Issues related to Hospice and the Medicare Advantage Program
Issues related to fraud in the Medicare Hospice Program Issues related to Hospice and the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2026 · first_quarter · Q1
Federal Financial Support for the American Biotech Industry
Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2025 · fourth_quarter · Q4
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands Issues related to the federal taxation of income earned in Puerto Rico
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2025 · fourth_quarter · Q4
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS Issues related to Hospice and the Medicare Advantage Program
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS Issues related to Hospice and the Medicare Advantage Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2025 · fourth_quarter · Q4
Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry
Federal Financial Support for the American Biotech Industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2025 · third_quarter · Q3
Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry
Federal Financial Support for the American Biotech Industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2025 · third_quarter · Q3
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2025 · third_quarter · Q3
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENCORA, INC. via INLET STRATEGIES
2025 · second_quarter · Q2
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
HR 1: The One Big Beautiful Bill Act Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2025 · second_quarter · Q2
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2025 · second_quarter · Q2
Issues related to domestic manufacturing of pharmaceuticals
Issues related to the federal governments procurement of Udenyca
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2025 · first_quarter · Q1
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Issues related to drug shortages and the medical supply chain Issues related to import tariffs on medical supplies issues related to the federal tax rate of corporations and their inventory
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2025 · first_quarter · Q1
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS
Issues related to the CMS Hospice Special Focus Program Issues related to the reimbursement of hospice care by CMS
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2025 · first_quarter · Q1
Issues related to the federal governments procurement of Udenyca
Issues related to the federal governments procurement of Udenyca
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2024 · fourth_quarter · Q4
Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D Issues related to the strategic national stockpile Issues related to the procurement of the medicine "Udenyca" for the treatment of acute radiation exposure
Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of biosimilars within Medicare Part D Issues related to the strategic national stockpile Issues related to the procurement of the medicine "Udenyca" for the treatment of acute radiation exposure
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2024 · fourth_quarter · Q4
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal by the Centers for Medicare and Medicaid Services
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal by the Centers for Medicare and Medicaid Services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2024 · fourth_quarter · Q4
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act
Filing targets: SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2024 · third_quarter · 3T
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness The American Made Pharmaceuticals Act Senate Finance Committee Draft Legislative Drug Shortage Proposal (Public)
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness Act Senate Finance Committee Draft Drug Shortage Legislative Proposal (Public)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2024 · third_quarter · Q3
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Filing targets: SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2024 · third_quarter · Q3
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal within the 2024 CMS home health proposed pay rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2024 · third_quarter · Q3
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness Act Senate Finance Committee Draft Drug Shortage Legislative Proposal (Public)
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness The American Made Pharmaceuticals Act Senate Finance Committee Draft Legislative Drug Shortage Proposal (Public)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2024 · third_quarter · Q3
Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2024 · second_quarter · Q2
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Filing targets: SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2024 · second_quarter · Q2
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal within the 2024 CMS home health proposed pay rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2024 · second_quarter · Q2
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness The American Made Pharmaceuticals Act Senate Finance Committee Draft Legislative Drug Shortage Proposal (Public)
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness Act Senate Finance Committee Draft Drug Shortage Legislative Proposal (Public)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2024 · second_quarter · Q2
Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2024 · first_quarter · Q1
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Filing targets: SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2024 · first_quarter · Q1
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal within the 2024 CMS home health proposed pay rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2024 · first_quarter · Q1
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness The American Made Pharmaceuticals Act
Issues related to drug shortages and the pharmaceutical supply chain The American Made Pharmaceuticals Act Reauthorization of the Pandemic and All-Hazards Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2024 · first_quarter · Q1
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CENCORA, INC. via INLET STRATEGIES
2024 · first_quarter · RR
Issues related to the distribution of pharmaceuticals. Issues related to drug shortages. Federal tax policy.
Issues related to the distribution of pharmaceuticals. Issues related to drug shortages. Federal tax policy.
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2023 · fourth_quarter · Q4
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal within the 2024 CMS home health proposed pay rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2023 · fourth_quarter · Q4
Issues related to drug shortages and the pharmaceutical supply chain The American Made Pharmaceuticals Act Reauthorization of the Pandemic and All-Hazards Preparedness Act
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness The American Made Pharmaceuticals Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2023 · fourth_quarter · Q4
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2023 · third_quarter · Q3
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity Issues related to the Hospice Special Focus Program proposal within the 2024 CMS home health proposed pay rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2023 · third_quarter · Q3
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness Act
Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2023 · third_quarter · Q3
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2023 · second_quarter · Q2
Issues related to Medicare reimbursement for Hospice care. Issues related to Hospice program integrity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2023 · second_quarter · Q2
Issues related to drug shortages and the pharmaceutical supply chain
Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2023 · second_quarter · Q2
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2023 · first_quarter · Q1
Issues related to drug shortages and the pharmaceutical supply chain
Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2023 · first_quarter · Q1
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2023 · first_quarter · Q1
Issues related to Medicare reimbursement for Hospice care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2022 · fourth_quarter · Q4
Issues related to Medicare reimbursement for Hospice Care. 2022 Consolidated Appropriations Act - Omnibus
Filing targets: SENATE
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2022 · fourth_quarter · Q4
Issues related to Medicare reimbursement for Hospice Care. 2022 Consolidated Appropriations Act - Omnibus
Filing targets: SENATE
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2022 · fourth_quarter · Q4
Issues related to drug shortages and the pharmaceutical supply chain
Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2022 · fourth_quarter · Q4
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
Filing targets: Health & Human Services, Dept of (HHS), SENATE, White House Office
VITAS HEALTHCARE CORPORATION via INLET STRATEGIES
2022 · fourth_quarter · RR
Issues related to Medicare reimbursement.
Issues related to Medicare reimbursement.
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2022 · third_quarter · Q3
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections
Filing targets: SENATE
SECURING AMERICA'S MEDICINES AND SUPPLY SAMS via INLET STRATEGIES
2022 · fourth_quarter · RR
Strengthen Domestic Medical Supply Chain. Promote Domestic Manufacturing of Medical Supplies.
Strengthen Domestic Medical Supply Chain. Promote Domestic Manufacturing of Medical Supplies.
Strengthen Domestic Medical Supply Chain. Promote Domestic Manufacturing of Medical Supplies.
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2022 · second_quarter · Q2
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform
Filing targets: Office of Management & Budget (OMB), SENATE
COHERUS BIOSCIENCES, INC via INLET STRATEGIES
2022 · second_quarter · RR
Medicare Reimbursements for Biosimilars Issues related to prescription drug pricing Issues related to domestic manufacturing incentives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE